| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tyra Biosciences, Inc. (TYRA) has 12 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. TYRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 570.0K | $17.18M | - | |
| COO | 300.0K | $9.04M | - | |
| Other | 200.0K | $6.03M | - | |
| Other | 163.0K | $4.91M | - | |
| CFO | 14.8K | $445.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2021 | Boxer Capital, LLC79 | 10% Owner | Buy | 125,000 | $13.12 | $1,640,312.50 | +2.0% | -3.6% | -44.0% | |
| Sep 17, 2021 | Boxer Capital, LLC79 | 10% Owner | Buy | 625,000 | $16.00 | $10,000,000.00 | +11.0% | -31.0% | -61.1% | |
| Sep 17, 2021 | More Robert J64 | Director | Buy | 156,250 | $16.00 | $2,500,000.00 | +4.0% | -31.0% | -61.1% | |
| Sep 17, 2021 | Alta Partners Nextgen Fund II Management, LLC | 10% Owner | Buy | 156,250 | $16.00 | $2,500,000.00 | +4.0% | -31.0% | -61.1% | |
| Sep 17, 2021 | Cormorant Asset Management, LP49 | Former 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +41.3% | -31.0% | -61.1% | |
| Sep 17, 2021 | Ra Capital Management, L.P.53 | Director, 10% Owner | Buy | 1,250,000 | $16.00 | $20,000,000.00 | +30.9% | -31.0% | -61.1% |